help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 20, 2006
Molecular Endocrinology, doi:10.1210/me.2005-0461
A more recent version of this article appeared on November 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
20/11/2711    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gummow, B. M.
Right arrow Articles by Hammer, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gummow, B. M.
Right arrow Articles by Hammer, G. D.

Submitted on November 17, 2005
Accepted on July 10, 2006

Reciprocal Regulation of a GR-SF-1 Transcription Complex on the Dax-1 Promoter by Glucocorticoids and ACTH in the Adrenal Cortex

Brian M. Gummow PhD, Joshua O. Scheys, Victoria R. Cancelli, and Gary D. Hammer MD, PhD*

University of Michigan Medical School; Department of Molecular and Integrative Physiology; Program in Cellular and Molecular Biology; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes; 109 Zina Pitcher Place, 1502 BSRB, Ann Arbor, MI 48109-2200

* To whom correspondence should be addressed. E-mail: ghammer{at}umich.edu.

Numerous genes required for adrenocortical steroidogenesis are activated by the nuclear hormone receptor SF-1 (NR5A1). Dax-1 (NR0B1), another nuclear hormone receptor, represses SF-1-dependent activation. Glucocorticoid products of the adrenal cortex provide negative feedback to the production of hypothalamic CRH and pituitary ACTH. We hypothesized that glucocorticoids stimulate an intra-adrenal negative feedback loop via activation of Dax-1 expression. Reporter constructs show glucocorticoid-dependent synergy between SF-1 and GR in the activation of Dax-1, which is antagonized by ACTH signaling. We map the functional GRE between -718bp and -704bp, required for activation by GR and synergy with SF-1. Of three SF-1 response elements, only the -128bp SF-1 response element is required for synergy with GR. ChIP assays demonstrate that dexamethasone treatment increases GR and SF-1 binding to the endogenous murine Dax-1 promoter 10-fold and 3.5-fold over baseline. Serial ChIP assays reveal that that GR and SF-1 are part of the same complex on the Dax-1 promoter while coimmunoprecipitation assay confirms the presence of a protein complex that contains both GR and SF-1. ACTH stimulation disrupts the formation of this complex by abrogating SF-1 binding to the Dax-1 promoter, while promoting SF-1 binding to the Mc2r and StAR promoters. Finally, dexamethasone treatment increases endogenous Dax-1 expression and concordantly decreases StAR expression. ACTH signaling antagonizes the increase in Dax-1 yet strongly activates StAR transcription. These data indicate that GR provides feedback regulation of adrenocortical steroid production through synergistic activation of Dax-1 with SF-1, which is antagonized by ACTH activation of the adrenal cortex.


Key words: Steroidogenic Factor-1 • Dax-1 • Glucocorticoid Receptor • Transcription Complex • Adrenal Cortex • HPA Axis • Steroidogenesis

NURSA Molecule Pages Link:

Nuclear Receptors:   DAX1  |  GR  |  SF-1
Ligands:   Dexamethasone



This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
L. J Martin and J. J Tremblay
Glucocorticoids antagonize cAMP-induced Star transcription in Leydig cells through the orphan nuclear receptor NR4A1
J. Mol. Endocrinol., September 1, 2008; 41(3): 165 - 175.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Zhou, R. H. Oakley, and J. A. Cidlowski
DAX-1 (Dosage-Sensitive Sex Reversal-Adrenal Hypoplasia Congenita Critical Region on the X-Chromosome, Gene 1) Selectively Inhibits Transactivation But Not Transrepression Mediated by the Glucocorticoid Receptor in a LXXLL-Dependent Manner
Mol. Endocrinol., July 1, 2008; 22(7): 1521 - 1534.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
X. Huang, B. Jiao, C. K. Fung, Y. Zhang, W. K K Ho, C. B. Chan, H. Lin, D. Wang, and C. H K Cheng
The presence of two distinct prolactin receptors in seabream with different tissue distribution patterns, signal transduction pathways and regulation of gene expression by steroid hormones
J. Endocrinol., August 1, 2007; 194(2): 373 - 392.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. A. Verrijn Stuart, G. Ozisik, M. A. de Vroede, J. C. Giltay, R. J. Sinke, T. J. Peterson, R. M. Harris, J. Weiss, and J. L. Jameson
An Amino-Terminal DAX1 (NROB1) Missense Mutation Associated with Isolated Mineralocorticoid Deficiency
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 755 - 761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society